Evidence map›Paper›PMID 34018674›Full record

ArticleCancer medicine2021

A population study of screening history and diagnostic outcomes of women with invasive cervical cancer.

Vicki B Benard, J Elizabeth Jackson, April Greek, Virginia Senkomago, Warner K Huh, Cheryll C Thomas, Lisa C Richardson

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Vicki B BenardDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-1989-0819
J Elizabeth JacksonBattelle, Seattle, Washington, USA.
April GreekBattelle, Seattle, Washington, USA.ORCID 0000-0003-4253-7511
Virginia SenkomagoDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-9291-8016
Warner K HuhUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0003-2881-9846
Cheryll C ThomasDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Lisa C RichardsonDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Centers for Disease Control and Prevention · USBattelle · USUniversity of Alabama at Birmingham · US

Funding

Treatment of HIV- and HIV+ Patients with HPV16+ CIN2/3 Using pNGLV4a-hCRTE6E7L2 DNA vaccine administered intramuscularly via electroporationP50CA098252 · NCI · JOHNS HOPKINS UNIVERSITY · PI TZYY-CHOOU WU · 2003 to 2026
$53.5M
CANCER PREVENTION & CONTROL PROGRAM FOR STATE, TERRITORIAL & TRIBAL ORGANIZATIONSU58DP003915 · DP · LSU HEALTH SCIENCES CENTER · PI WILLIAMS, DONNA L. · 2012 to 2014
$8.9M
NCCDPHP CDC HHS U58 DP003915NCI NIH HHS HHSN261201200021INCI NIH HHS HHSN261201300016INCI NIH HHS P50 CA098252
6 · The paper itself

Abstract

backgroundDespite advances to prevent and detect cervical cancer, national targets for screening have not been met in the United States. Previous studies suggested that approximately half of women who developed cervical cancer were not adequately screened. This study aimed to provide an updated examination of women's screening and diagnostic practices five years prior to an invasive cervical cancer diagnosis.

methodsThe study included women age 21 years and older diagnosed with invasive cervical cancer in 2013-2016 from three population-based state cancer registries in the United States. Medical records abstraction identified screening history and diagnostic follow-up. A mailed survey provided sociodemographic data. Screening was a Pap or human papillomavirus (HPV) test between 6 months and 5 years before diagnosis. Adequate follow-up was defined per management guidelines.

resultsOf the 376 women, 60% (n = 228) had not been screened. Among women who received an abnormal screening result (n = 122), 67% (n = 82) had adequate follow-up. Predictors of: (a) being screened were younger age, having a higher income, and having insurance; (b) adequate follow-up were having a higher income, and (c) stage 1 cervical cancer were being screened and younger age.

conclusionUnlike other cancer patterns of care studies, this study uses data obtained from medical records supplemented with self-report information to understand a woman's path to diagnosis, her follow-up care, and the stage of her cervical cancer diagnosis. This study provides findings that could be used to reach more unscreened or under screened women and to continue lowering cervical cancer incidence in the United States.

Indexed as

AdultAftercareAgedAge FactorsCancer SurvivorsEarly Detection of CancerFemaleHealth Records, PersonalHumansIncomeInsurance, HealthLouisianaMichiganMiddle AgedNeoplasm StagingNew Jerseycancer registriescervical cancer screeningcervical cancer survivors

Identifiers

PMID34018674
PMCPMC8209614
OpenAlexW3163318605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.